Dinah Miller, MD

The final installment in this journal on ketamine.

How does ketamine-assisted psychotherapy help real world patients?

A review of Marty Makary’s Blind Spots: When Medicine Gets It Wrong and What It Means for Our Health (Bloomsbury, 2024).

Dr Miller continues her Ketamine Journal with a mini-group of 2 patients and a cofacilitator.

Should ketamine be used at all when FDA-approved Spravato is available and insurance will pay for it?

Outpatient civil commitment in Maryland will go into effect in July 2025. Learn more here.

After months of preparation, one psychiatrist starts using KAP in her practice.

A mainstream psychiatrist finds herself exploring a treatment that is off the radar for most.

Learn more about one psychiatrist’s personal experiential learning process with ketamine.

A look into the experiential learning process involving ketamine.

Getting ready to do ketamine-assisted psychotherapy requires a lot of preparation.

Learning to use a psychedelic agent can be challenging when the protocols are not defined. Here’s how a psychiatrist got started.

A psychiatrist explores ketamine-assisted psychotherapy in this ongoing series.

Ultimately, the decision about involuntary treatment is about risk, not predictable outcomes. In many cases, however, these decisions are much more difficult and, until our crystal balls arrive, our best efforts may still fall short.